Publique un comentario 
Serotipos de Streptococcus pneumoniae responsables de enfermedad invasiva en niños cubanos
Texto completo:
HTMLResumen
Referencias
WHO. Pneumococcal vaccines WHO position paper –2012–recommendations. Vaccine. 2012;30(32):4717-8.
Center for Disease Control and Prevention.
Pneumococcal Disease Epidemiology and prevention of vaccine-preventable diseases. 12th edtion. Atlanta. Center for Disease Prevention and Control 2011.pp 233-248.
Pérez A, Dickinson F, Rodriguez M. Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infectious Diseases. 2010 Disponible en: http://www.biomedcentral.com/1471-2334/10/130.
Dickinson F, RodrÃguez M, Toraño G. Pneumococcal meningitis in Cuban children and adolescents: A fifteen years follow up. Pediatrics Research International Journal 2015 Disponible en: http://www.ibimapublishing.com/journals/PRIJ/PRIJ.html Article ID 596251, DOI: 10.5171/2015.
Toraño G, Llanes R, PÃas L, Abreu M, Varcárcel M. Serotipos de Streptococcus pneumoniae en Cuba y progresión de la resistencia a la penicilina. Rev Cubana Med Trop 2010; Vol.62, No.2.
Toraño G, PÃas L, Capote M, RodrÃguez M, Dickinson F, Varcárcel M. Serotipos y resistencia antimicrobiana de aislamientos menÃngeos de Streptococcus pneumoniae. Cuba, 2007-2012. VacciMonitor 2014;23(3):117-123.
González N, Paredes B, Pérez S, Mirabal M, Rivero I, González C, et al. Safety and Immunogenicity of Cuban Antipneumococcal Conjugate Vaccine PCV7-TT in Healthy Adults. MEDICC Review 2015;17(4):32-37.
Dotres C, Puga R, Ricardo Y, Broño C, Paredes B, EchemendÃa V et al. Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial. Vaccine 2014;32(41):5266–5270.
Linares-Pérez N, Toledo-Romanà ME, GarcÃa-Rivera D, Valdés-Balbin Y, Verez-Bencomo V y el Grupo de Trabajo de Ensayos ClÃnicos y Evaluación de Impacto de la Vacuna Neumoccócica Cubana. Model for clinical and impact evaluation of the new Cuban (Oral Presentation) VacciPharma International Conference. Varadero, Cuba, 2015.
Perilla MJ, Ajello G, Bopp C, Elliott J, Facklam R, Knapp J, et al. Manual de Laboratorio para la Identificación y Prueba de Susceptibilidad a los Antimicrobianos de patógenos Bacterianos de Importancia para la Salud Pública en el Mundo en Desarrollo; 2003. WHO/CDC/CSR/RMD/2003.6. Atlanta.
Habib M, Porter BD, Satzke C. Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction. J Vis Exp 2014(84), e51208, doi:10.3791/51208.
Said M, Johnson H, Nonyane B, Deloria-Knoll M, O’Brien KL, Andreo F et al. Estimating the burden of pneumococcal pneumonia among adults a systematic review and meta-analysis of diagnostic techniques. PLoS ONE.20138e60273.
Geno K, Gilbert G, Song J, Skovsted I, Klugman K, Jones C, et al. Pneumococcal Capsules and Their Types: Past, Present, and Future. Clinical Microbiology Reviews. 2015;28(3):871-99.
Johnson H, Deloria-Knoll M, Levine O, Stoszek S, Freimanis Hance L, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10).
Darenberg J, Henriques Normark B. The epidemiology of pneumococcal infections-the Swedish experience. Vaccine. 2009;27 Suppl 6:G27-32.
Van Effelterre T, Moore M, Fierens F, Whitney C, White L, Pelton S, et al. A dynamic model of pneumococcal infection in the United States. Implications for prevention through vaccination. Vaccine. 2010;28:3650-60.
Isaacman D, McIntosh D, Reinert R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines Inter J Infect Dis 201014197-209.
Castañeda E, Agudelo CI, Regueira M, Corso A, Brandileone MC, Brandao A, et al. Laboratory-Based Surveillance of Streptococcus pneumoniae Invasive Disease in Children in 10 Latin American Countries. SIREVA II Project, 2000–2005. Pediatric Infec Dis J 2009;28(9):265-70.
Vakevainen M, Eklund C, Eskola J, Kayhty H. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis. 2001;184(6):789-93.
Kuttel M, Jackson G, Mafata M, Ravenscroft N. Capsular polysaccharide conformations in pneumococcal serotypes 19F and 19A. Carbohydrate research. 2015;406:27-33.
Hausdorff W, Hoet B, Schuerman L. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? BMC Pediatrics. 2010;10:4.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2017 Gilda Teresa Toraño Peraza, Daniela Suárez Aspaza, Miriam Abreu Capote, Brenda Barreto Núnez, Eugenia Toledo RomanÃ, Nivaldo Linares Pérez
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.
